This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
coronavirus: Archive
Bear of the Day: Quidel (QDEL)
by Kevin Cook
Rising star in diagnostics had a shot at big cap status with 200% growth on COVID testing that faded
coronavirus medical
Best Biotech Stocks & ETFs for mRNA, Gene Editing
by Neena Mishra
Here is what you should know about investing in these life changing technologies.
biotechs coronavirus
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Delay in FDA approval for latest COVID test hasn't altered growth or value at 3X sales
biotechs coronavirus medical
One Year Later: Lessons from the Coronavirus Stock Sell-Off
by Tracey Ryniec
What did you do with your investment portfolio when the coronavirus crisis hit in spring of 2020?
coronavirus stock-performance stock-price-movement value-stocks
5 Hot Upcoming Earnings Charts
by Tracey Ryniec
Earnings season is winding down over the next 2 weeks but there are still incredible earnings charts still to come.
coronavirus earnings
Vaccine Miracles: Does JNJ Kill the Profit Path for MRNA and NVAX?
by Kevin Cook
New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt.
biotechs coronavirus pharmaceuticals
5 Pandemic Winner Earnings Charts
by Tracey Ryniec
These 5 companies were beneficiaries of the pandemic economy. But what happens next?
coronavirus earnings
Hedge Fund Diaries: Who Was Buying Your Stocks?
by Kevin Cook
SEC 13Fs reveal trades from months ago, but also patterns of long-term bullish behavior.
coronavirus economy stock-performance
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 30%+ to over $335 million on COVID-19 testing and its mutations
coronavirus medical
Bear Of The Day: Chico's (CHS)
by Daniel Laboe
This stock is trading far above the most optimistic price targets and I would liquidate any positions that I had in CHS, thanking god that I was able to get such a good price for them
apparel coronavirus retail